Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Diabetes Devices Companies

In the realm of diabetes care, Diabetes Devices companies lead in developing technology-driven solutions. Specializing in devices such as insulin pumps and continuous glucose monitors, they empower individuals with diabetes to manage their condition effectively, promoting better health outcomes and quality of life.

Diabetes Devices Key Companies

 


Latest Diabetes Devices Companies Update:

Abbott's acquisition of Dexcom in July 2023 has shaken the market, creating a diabetes care powerhouse with dominance in both continuous glucose monitoring (CGM) and blood glucose monitoring.


Insulet Corporation acquires Tandem Diabetes Care in September 2023, consolidating the insulin pump market and focusing on developing next-generation closed-loop systems.


Medtronic unveils the MiniMed 780G insulin pump, the first hybrid closed-loop system approved in the US, offering automated insulin adjustments based on CGM data.


Dexcom launches the G7 CGM system, featuring enhanced accuracy and extended sensor wear time, and plans to introduce a G7 model for non-insulin-dependent individuals in summer 2024.


Abbott introduces the FreeStyle Libre 3 sensor, boasting a thinner profile and integrated Bluetooth connectivity for seamless data transmission to smartphones.


List of Diabetes Devices Key companies in the market

  • Abbott Laboratories

  • Hoffmann-La-Ltd.

  • Bayer AG

  • Lifescan, Inc.

  • B Braun Melsungen AG

  • Dexcom Inc.

  • Insulet Corporation

  • Ypsomed Holdings

  • Companion Medical

  • Sanofi

  • Valeritas Holding Inc

  • Novo Nordisk

  • Arkray, Inc.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.